A5043634118- Otitis Media and Relapsing Polychondritis
- Vasculitis and related conditions
- Parasitic Diseases Research and Treatment
- Childhood Cancer Survivors' Quality of Life
- Cancer Diagnosis and Treatment
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Colorectal and Anal Carcinomas
- Colorectal Cancer Treatments and Studies
- Urticaria and Related Conditions
Universidad CES
2022
Soma Central Hospital
2021
Therapy for mCRC is based on surgery, cytotoxic chemotherapy, and biologic agents. In randomized clinical trials, median progression-free survival (PFS) overall (OS) hover around 10mo 29mo, respectively. There are no published results outcomes of patients with in Colombia. Objective: Describe the treated by Mauricio Lema Medellín, Methods: This a retrospective, case series (2008-2020) mCRC, ≥18 years old, systemic therapy metastatic disease, ≥3-month follow-up. Stratification factors...
Purpose: To evaluate the clinical efficacy of including Ivermectin (single dose on day 1 400 ug/kg PO) in standard care hospitalized adults with severe COVID-19. Methods: Double-blinded, parallel, placebo-controlled, single-center, randomized trial. Seventy-five patients were randomly assigned (1:1) to receive plus ivermectin or placebo and followed up for 21 days. Primary outcome measure was admission ICU secondary outcomes requirement intensive mechanical ventilation (IMV) in-hospital...